Novonesis (Novozymes) B (STU:NZM2)
€ 56.62 0.52 (0.93%) Market Cap: 26.38 Bil Enterprise Value: 28.11 Bil PE Ratio: 39.62 PB Ratio: 2.44 GF Score: 97/100

Novozymes A/S Annual Shareholders Meeting Transcript

Mar 02, 2023 / 03:00PM GMT
Release Date Price: €46.16 (+0.68%)
JÃ;rgen Buhl Rasmussen

¸ -

It now 4:00, and we're about to embark on the shareholders' meeting. Welcome, dear shareholders. Welcome to our Annual Shareholders Meeting 2023. We are pleased to welcome you all to Ballerup Super Arena, and we look forward to spending the afternoon with you. I also hope once the meeting is over, that you'll join us for some refreshments.

Personally, I look very much forward to presenting the great work and progress we've made in 2022 on our path to finding biological answers for better lives in a growing world. I also look forward to presenting where Novozymes is heading in the coming years and how we plan to increase our positive impact towards a healthier planet, all while creating strong, sustainable growth and attractive returns to our shareholders.

This naturally includes our recently announced plans to combine with Chr. Hansen to create a leading and truly global biotechnology power center, what we call a biotech powerhouse. I'll come back to this later. My name is Jorgen Buhl Rasmussen. I am Chair of the Board of Directors of Novozymes and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot